CCR2 and brain neoplasm: To determine if CCR2+HSCs are responsible for the enhanced efficacy of stem cell transfer in adoptive cellular therapy targeting brain tumors, purified CCR2+HSCs vs. CCR2−HSCs were transferred in conjunction with adoptive cellular therapy in mice receiving non-myeloablative conditioning (5 Gy total body irradiation).